Daiwa Capital Markets America’s Bristol-Myers Squibb BMY Stock Holding History

Daiwa Capital Markets America’s Portfolio BMY Stock Details BMY Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2013 Q4	$6.29M	Buy	+118,300	New	+$6.03M	0.05%	125

Other funds holding BMY

Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

BIT

BlackRock Institutional Trust San Francisco, California $675B AUM 16.26% 1-Year Est. Return

JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

Jennison Associates New York $167B AUM 44.17% 1-Year Est. Return

Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return

Bank of New York Mellon New York $609B AUM 40.19% 1-Year Est. Return

BFA

BlackRock Fund Advisors San Francisco, California $542B AUM 18.14% 1-Year Est. Return

Daiwa Capital Markets America's BMY Position: Q4 2013 in Review

Daiwa Capital Markets America opened a new position in Bristol-Myers Squibb (BMY) in Q4 2013: 118,300 shares worth $6.29M. The stake represents 0.05% of the portfolio and ranks #125 among its holdings.

1,314 funds tracked by Wall St. Rank hold BMY as of Q4 2013.

Daiwa Capital Markets America held 118,300 shares of Bristol-Myers Squibb worth $6.29M as of Q4 2013.
Bristol-Myers Squibb was a new Daiwa Capital Markets America position in Q4 2013.
Bristol-Myers Squibb made up 0.05% of Daiwa Capital Markets America's portfolio in Q4 2013, its #125 holding.
1,314 funds tracked by Wall St. Rank held Bristol-Myers Squibb as of Q4 2013.

Based on Daiwa Capital Markets America's 13F filing for Q4 2013, filed 13 Feb 2014.